Delivery Order SPE2DB20D3111-SPE2DB26FA5MN
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Vivitrol 380 mg vials with diluents, valued at $4,004.64. This non-set-aside contract represents a firm fixed-price delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $3,017.66 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials with diluents. The contract, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, operates under firm fixed price terms with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its Corporate Office location. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,002.34 to AmerisourceBergen Drug Corp for Vivitrol 380 mg vial with diluents. This contract, awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a firm fixed price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vivitrol is a medication used in the treatment of opioid and alcohol use...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials and diluents, with a ceiling value of $8,844.95. This is a firm fixed price, non-set-aside contract awarded on September 9, 2025, with an ultimate completion date of September 10, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $22,966.57 delivery order for Vivitrol 380 mg vial-diluents, with a completion date of August 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a child contract under AmerisourceBergen's larger pharmaceutical supply agreements with DLA. The pharmaceutical products will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $2,002.34 to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Vivitrol 380 mg vial-diluents. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 16, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. Vivitrol is an extended-release naltrexone injection used in substance use disorder treatment, representing part of...
- The Defense Logistics Agency awarded a $18,442.74 delivery order to AmerisourceBergen Drug Corp for Vivitrol 380 mg vial-diluents, with an ultimate completion date of September 29, 2025. This non-competitive award was issued on September 26, 2025, under a firm fixed-price contract type. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $11,451.68 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents. The contract is firm fixed price, non-competitive set-aside, with an ultimate completion date of July 29, 2025, just one day following the award date of July 28, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $3,003.51 to AmerisourceBergen Drug Corp for VIVITROL 380 mg vial-diluents, with an ultimate completion date of September 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a $999.999 billion ceiling value through December 2026. The place of...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 13, 2025, for the supply of Vivitrol 380 mg vials with diluents. This is a firm fixed-price delivery order with a ceiling value of $6,007.02 and an ultimate completion date of August 14, 2025. The contract carries no set-aside designation, indicating it was competitively awarded through open competition. The place of performance is AmerisourceBergen's corporate office location in...
- SPE2DB20D3111Indefinite Delivery Contract
- SPE2DB20D3111-SPE2DB26FA5MNDelivery Order
The Defense Logistics Agency awarded a $3,003.48 delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Vivitrol 380 mg vial-diluents. This is a firm fixed-price contract with an ultimate completion date of October 23, 2025, and represents a non-competitive, non-set-aside award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle valued through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare systems worldwide. Vivitrol (naltrexone extended-release) is a medication used in opioid use disorder treatment and alcohol dependence management, making this supply critical for supporting military medical readiness and veteran healthcare initiatives. AmerisourceBergen's status as a major pharmaceutical distributor and a prime vendor for the DLA Medical Supply Chain positions it as a key provider for federal healthcare procurement. The company's demonstrated capability to manage both high-volume and specialized pharmaceutical products across multiple therapeutic domains, combined with its extensive federal contract portfolio, underscores its role as an essential logistics partner for Department of Defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 10/22/25 |